Craft

enVVeno

Stock Price

$8.3

2021-11-10

Market Capitalization

$88.4 M

2021-11-10

Revenue

$31.2 K

FY, 2019

enVVeno Summary

Company Summary

Overview
Envveno Medical (formerly known as Hancock Jaffe) is a company developing biologic-based solutions that are designed to be life enhancing for patients with cardiovascular disease, peripheral arterial and venous disease, and end stage renal disease (ESRD). The Company develops bioprosthetic implantable devices for cardiovascular disease. Its Bioprosthetic Heart Valve (BHV), is a bioprosthetic, pig heart valve designed to function like a native heart valve, and designed to provide a patient greater functional performance than available devices.
Type
Public
Status
Active
Founded
1987
HQ
Irvine, CA, US | view all locations
Website
https://envveno.com/
Cybersecurity rating
Sectors

Key People

  • Robert Berman

    Robert Berman, Chief Executive Officer and Director

  • Francis Duhay, Director

    • Robert Gray, Director

      • Hamed Alavi

        Hamed Alavi, Vice President of Research and Development and Quality

      LocationsView all

      1 location detected

      • Irvine, CA HQ

        United States

        70 Doppler

      enVVeno Financials

      Summary Financials

      Net income (Q1, 2026)
      ($3.8M)
      Cash (Q1, 2026)
      $2.6M
      EBIT (Q1, 2026)
      ($4.1M)
      Enterprise value
      $86.4M

      Footer menu